Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.6059
+0.0183 (3.11%)
At close: Oct 23, 2026, 4:00 PM EDT
0.6040
-0.0019 (-0.31%)
After-hours: Oct 23, 2026, 7:58 PM EDT
Rani Therapeutics Holdings Employees
As of December 31, 2025, Rani Therapeutics Holdings had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees decreased by 35 or 33.02% compared to the previous year. That makes Rani Therapeutics Holdings the 33,494th largest employer in the world and 4,406th in the United States.
Employees
71
Change (1Y)
-35
Growth (1Y)
-33.02%
Revenue / Employee
$68,690
Profits / Employee
-$424,521
Market Cap
84.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 71 | -35 | -33.02% | 69 | 2 |
| Dec 31, 2024 | 106 | -34 | -24.29% | 105 | 1 |
| Dec 31, 2023 | 140 | -23 | -14.11% | 140 | 0 |
| Dec 31, 2022 | 163 | 49 | 42.98% | 163 | 0 |
| Dec 31, 2021 | 114 | 43 | 60.56% | 114 | 0 |
| Sep 30, 2021 | 91 | 20 | 28.17% | 91 | 0 |
| Jun 30, 2021 | 78 | - | - | 78 | 0 |
| Mar 31, 2021 | 71 | - | - | 71 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Tenaya Therapeutics | 70 |
| Milestone Pharmaceuticals | 38 |
| Corbus Pharmaceuticals Holdings | 36 |
| Genelux | 26 |
| PDS Biotechnology | 21 |
| Equillium | 15 |
| Atara Biotherapeutics | 10 |
RANI News
- 4 days ago - Rani Therapeutics Holdings Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 11 days ago - Rani Therapeutics to Participate in the Chardan Healthcare Conference - GlobeNewsWire
- 19 days ago - Rani reports RaniPill acceptance into FDA Emerging Technology Program - TheFly
- 19 days ago - Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP) - GlobeNewsWire
- 5 weeks ago - Rani Therapeutics Holdings Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Rani Therapeutics to Participate in Upcoming September Conferences - GlobeNewsWire
- 2 months ago - Rani Therapeutics initiated with a Buy at Chardan - TheFly
- 2 months ago - Rani Therapeutics reports Q2 EPS (4c), consensus (5c) - TheFly